SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-020052
Filing Date
2007-03-16
Accepted
2007-03-16 16:40:08
Documents
7
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-5560_110k.htm 10-K 1464634
2 EX-10.56 a07-5560_1ex10d56.htm EX-10.56 231446
3 EX-10.57 a07-5560_1ex10d57.htm EX-10.57 68806
4 EX-23.0 a07-5560_1ex23d0.htm EX-23.0 4216
5 EX-31.1 a07-5560_1ex31d1.htm EX-31.1 14535
6 EX-31.2 a07-5560_1ex31d2.htm EX-31.2 14555
7 EX-32.0 a07-5560_1ex32d0.htm EX-32.0 6831
  Complete submission text file 0001104659-07-020052.txt   1806530
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14895 | Film No.: 07700639
SIC: 2834 Pharmaceutical Preparations